v3.26.3
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2024 $ 72,750 $ (82,154) $ (9,404)
Balance, shares at Dec. 31, 2024 90,408      
Net loss (6,797) (6,797)
Common stock issued in public offering (ATM), net of costs 63 63
Common stock issued in public offering (ATM), net of costs, shares   290      
Redeemable preferred stock issued, net $ 3,180
Redeemable preferred stock issued, net, shares 350        
Shares issued for vested restricted stock units
Shares issued for vested restricted stock units, shares   274      
Conversion of preferred to common stock $ (273) 273 273
Conversion of preferred stock to common stock, shares (30) 3,899      
Stock compensation expense 220 220
Balance at Mar. 31, 2025 $ 2,907 73,306 (88,951) (15,645)
Balance, shares at Mar. 31, 2025 320 94,871      
Balance at Dec. 31, 2024 72,750 (82,154) (9,404)
Balance, shares at Dec. 31, 2024 90,408      
Net loss         (24,901)
Balance at Sep. 30, 2025 85,478 (107,055) (21,577)
Balance, shares at Sep. 30, 2025 771,777      
Balance at Mar. 31, 2025 $ 2,907 73,306 (88,951) (15,645)
Balance, shares at Mar. 31, 2025 320 94,871      
Net loss (7,034) (7,034)
Redeemable preferred stock issued, net $ 4,150
Redeemable preferred stock issued, net, shares 450        
Shares issued for vested restricted stock units
Shares issued for vested restricted stock units, shares   804      
Conversion of preferred to common stock $ (5,812) 5,812 5,812
Conversion of preferred stock to common stock, shares (634) 371,061      
Stock compensation expense 190 190
Share issuance under ESPP 73 73
Share issuance under ESPP, shares   1,094      
Balance at Jun. 30, 2025 $ 1,245 79,381 (95,985) (16,604)
Balance, shares at Jun. 30, 2025 136 467,830      
Net loss (11,070) (11,070)
Shares issued for vested restricted stock units
Shares issued for vested restricted stock units, shares   224      
Conversion of preferred to common stock $ (1,245) 1,245 1,245
Conversion of preferred stock to common stock, shares (136) 28,973      
Stock compensation expense 168 168
Common stock issued in public offering, net 4,684 4,684
Common stock issued in public offering, net, shares   274,750      
Balance at Sep. 30, 2025 85,478 (107,055) (21,577)
Balance, shares at Sep. 30, 2025 771,777      
Balance at Dec. 31, 2025 163,623 (152,093) 11,530
Balance, shares at Dec. 31, 2025 1,509,839      
Net loss (6,625) (6,625)
Shares issued for vested restricted stock units
Shares issued for vested restricted stock units, shares   11      
Stock compensation expense 100 100
Cashless exercise of liability classified as warrants
Cashless exercise of liability classified warrants, shares   8,748      
Dividends Preferred Series B - Paid-in-kind (125) (125)
Dividends Preferred Series B (502) (502)
Accretion of discount on Series B Preferred (468) (468)
Balance at Mar. 31, 2026 162,628 (158,718) 3,910
Balance, shares at Mar. 31, 2026 1,518,598      
Balance at Dec. 31, 2025 163,623 (152,093) 11,530
Balance, shares at Dec. 31, 2025 1,509,839      
Net loss         (16,550)
Balance at Sep. 30, 2026 164,099 (168,643) (4,544)
Balance, shares at Sep. 30, 2026 1,878,418      
Balance at Mar. 31, 2026 162,628 (158,718) 3,910
Balance, shares at Mar. 31, 2026 1,518,598      
Net loss (4,386) (4,386)
Common stock issued in public offering (ATM), net of costs 829 829
Common stock issued in public offering (ATM), net of costs, shares   51,388      
Shares issued for vested restricted stock units
Shares issued for vested restricted stock units, shares   21,634      
Stock compensation expense 374 374
Share issuance under ESPP 26 26
Share issuance under ESPP, shares   2,184      
Cashless exercise of liability classified as warrants 193 193
Cashless exercise of liability classified warrants, shares   12,924      
Dividends Preferred Series B - Paid-in-kind (127) (127)
Dividends Preferred Series B (510) (510)
Accretion of discount on Series B Preferred (494) (494)
Exercise of Pre-Funded Underwriters Warrants 1 1
Exercise of Pre-Funded Underwriters Warrants, shares   62,500      
Balance at Jun. 30, 2026 162,920 (163,104) (184)
Balance, shares at Jun. 30, 2026 1,669,228      
Net loss (5,539) (5,539)
Common stock issued in public offering (ATM), net of costs 202 202
Common stock issued in public offering (ATM), net of costs, shares   21,270      
Shares issued for vested restricted stock units
Shares issued for vested restricted stock units, shares   420      
Stock compensation expense 243 243
Dividends Preferred Series B - Paid-in-kind (130) (130)
Dividends Preferred Series B (518) (518)
Accretion of discount on Series B Preferred (520) (520)
Adjustment for prior quarter warrant exercise 147 147
Issuance of common stock pursuant to the Asset Purchase Agreement 1,755 1,755
Issuance of common stock pursuant to the Asset Purchase Agreement, shares   187,500      
Balance at Sep. 30, 2026 $ 164,099 $ (168,643) $ (4,544)
Balance, shares at Sep. 30, 2026 1,878,418